ERCP临床病例数据库的建立及其应用(2)
 |
| 第1页 |
参见附件(323KB，2页)。
[参考文献]
[1]Cotton PB. Analysis of 59 ERCP lawsuits: mainly about indications[J]. Gastrointest Endosc, 2006, 63(3): 378-382.
[2]Testoni PA. Facts and fiction in the pharmacologic prevention of post-ERCP pancreatitis: a never-ending story[J].Gastrointest Endosc,2006, 64(5): 732-734.
[3]Andriulli A, Leandro G, Niro G, et al. Pharmacologic treatmentcan prevent pancreatic injury after ERCP: a meta-analysis[J].Gastrointest Endosc, 2000, 51(1):1-7.
[4]Manolakopoulos S, Avgerinos A, Vlachogiannakos J,et al. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial[J]. Gastrointest Endosc, 2002，55(4):470-475.
[5]Arvanitidis D, Anagnostopoulos GK, Giannopoulos D, et al. Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial [J]. J Gastroenterol Hepatol, 2004, 19(3):278-282.
[6]但汉雷，孙凤蓬，张亚历，等.大肠息肉病例数据库系统的建立与应用[J].第一军医大学学报, 2002，22(2) :177-178.
[7]巨邦律，方驰华，钟洪才，等.肝内胆管结石Access数据库的建立及其应用[J].第四军医大学学报, 2005，26(5): 428-430.
[8]钟洪才，方驰华，巨邦律，等.Access 原发性肝癌数据库的建立及其应用价值初探[J].第四军医大学学报,2004， 25(21): 2011-2013.
(收稿日期：07-04-20)
“本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文”。
您现在查看是摘要介绍页，详见PDF附件(323KB，2页)。